New Blood Biomarker Identifies Status of Fatty Liver Disease
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Company News, Diagnostic Technologies |
LightDeck Diagnostics has been awarded a grant to build a rapid, portable, quantitative test to detect many PFAS simultaneously.
Read MorePosted by Andy Lundin | Jun 21, 2022 | Covid 19, Fluid Handling & Pipetting Systems |
Matrix Diagnostics—a COVID testing lab based in California—is relying on INTEGRA Biosciences’ pipettes to streamline its PCR workflows.
Read MorePosted by Andy Lundin | Jun 21, 2022 | Womens Health |
Yourgene Health launched a new solution which aims to help NIPT providers reduce no-call rates by optimizing average fetal fraction.
Read MorePosted by Chris Wolski | Jun 20, 2022 | Unknown Origin & Other Cancer Types |
Researchers introduced a new glycoproteomics approach called high-throughput intact glycopeptides quantitation strategy (HTiGQs).
Read More